1986
DOI: 10.1111/j.1471-4159.1986.tb04537.x
|View full text |Cite
|
Sign up to set email alerts
|

A and B Forms of Monoamine Oxidase Within the Monoaminergic Neurons of the Rat Brain

Abstract: The inhibition of the A and B forms of monoamine oxidase (MAO) inside and outside serotonergic, noradrenergic, and dopaminergic synaptosomes in homogenates of rat hypothalamus or striatum by clorgyline, a selective and irreversible MAO-A inhibitor, and selegiline, a selective and irreversible MAO-B inhibitor, was examined. Intrasynaptosomal deamination at low concentrations of the substrates ['4C]5-hydroxytryptamine ([14Cj5-HT; 0.1 p M ) , [14C]noradrenaline (0.25 p M ) , [14C]3,4-dihydroxyphenylethylarnine ([… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0

Year Published

1988
1988
2017
2017

Publication Types

Select...
6
4

Relationship

1
9

Authors

Journals

citations
Cited by 68 publications
(10 citation statements)
references
References 26 publications
0
10
0
Order By: Relevance
“…However, the patient (ASD-38) reported here to carry PDK3 splice site variant is not affected with Charcot-Marie-Tooth disease, nor does he suffer from any type of neuropathy. Moreover, of the variants detected on the X-chromosome, four were located in genes involved in brain function/development ( PLP1 76 , MAOB 77 , USP9X 78 , and FLNA 79, 80 ) and two were present in genes regulating splicing and/or transcription ( HTATSF1 81 and GPKOW 82, 83 ). Additional rare variants were identified in genes involved in: (i) the hydrolysis of angiotensin II ( ACE2 ) 84 or sulfate esters ( IDS ) 85 and ( ARSH ) 86 ; (ii) or in the ubiquitination and proteasomal degradation of creatine kinase-B ( ASB - 9 ) 87 .…”
Section: Discussionmentioning
confidence: 99%
“…However, the patient (ASD-38) reported here to carry PDK3 splice site variant is not affected with Charcot-Marie-Tooth disease, nor does he suffer from any type of neuropathy. Moreover, of the variants detected on the X-chromosome, four were located in genes involved in brain function/development ( PLP1 76 , MAOB 77 , USP9X 78 , and FLNA 79, 80 ) and two were present in genes regulating splicing and/or transcription ( HTATSF1 81 and GPKOW 82, 83 ). Additional rare variants were identified in genes involved in: (i) the hydrolysis of angiotensin II ( ACE2 ) 84 or sulfate esters ( IDS ) 85 and ( ARSH ) 86 ; (ii) or in the ubiquitination and proteasomal degradation of creatine kinase-B ( ASB - 9 ) 87 .…”
Section: Discussionmentioning
confidence: 99%
“…The drug doses used in our study are consistent with previous investigations on the MAO‐inhibiting effects of these drugs. Indeed, chronic treatment with CLOR (2 mg/kg/day) affords complete inhibition of MAO‐A in rats (MAO‐A, 90%; MAO‐B, 10%) (Fagervall & Ross, 1986; Todd & Baker, 1995) and is sufficient to irreversibly inhibit MAO‐A for more than 24 h (Lamensdorf et al. , 1996).…”
Section: Discussionmentioning
confidence: 99%
“…The proportion between these two ways under in vivo conditions is not known. However, when brain synaptosomes are incubated with low nmol concentrations of radioactive 5-HT rapid formation of 5-HIAA occurs inside the 5-HT synaptosomes (Ross and Ask 1980;Fagervall and Ross 1986). It is therefore likely that a considerable part of the 5-HT taken up is deaminated to 5-HIAA under in vivo conditions.…”
Section: Source Of the Extracellular 5-hiaamentioning
confidence: 98%